Watchlist Price Alert

PAVmed Inc. (PAVM)

NASDAQ: PAVM · Real-Time Price · USD

0.63

-0.01 (-1.33%)

At close: Jun 16, 2025, 3:59 PM

-1.33% (1D)

Bid	0.61
Market Cap	10.9M
Revenue (ttm)	9.98M
Net Income (ttm)	17.75B
EPS (ttm)	3.46
PE Ratio (ttm)	0.18
Forward PE	-0.98
Analyst	Buy

Ask	0.69
Volume	92,610
Avg. Volume (20D)	164,207
Open	0.64
Previous Close	0.64
Day's Range	0.62 - 0.65
52-Week Range	0.55 - 1.90
Beta	1.06

About PAVM

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol PAVM

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for PAVM stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Why Price Moved

1 month ago

-13.72%

PAVmed shares are trading lower after the company ... Unlock content with Pro Subscription

2 months ago

+7.31%

PAVmed shares are trading higher on possible continued strength after the company reported a Q4 adjusted EPS beat on Tuesday.

News

1 month ago · seekingalpha.com

PAVmed Inc. (PAVM) Q1 2025 Earnings Call Transcript

PAVmed Inc. (NASDAQ:PAVM ) Q1 2025 Earnings Conference Call May 15, 2025 8:30 AM ET Company Participants Matt Riley - Senior Director of Investor Relations Lishan Aklog - Chairman and Chief Executive ...

1 month ago · zacks.com

PAVmed (PAVM) Upgraded to Buy: Here's What You Should Know

PAVmed (PAVM) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

2 months ago · seekingalpha.com

PAVmed Inc. (PAVM) Q4 2024 Earnings Call Transcript

PAVmed Inc. (NASDAQ:PAVM ) Q4 2024 Earnings Conference Call March 25, 2025 8:30 AM ET Company Participants Matt Riley - Senior Director of IR Lishan Aklog - Chairman and CEO Dennis McGrath - CFO Confe...